CANNAPHARMARX, INC.
Close on Oct 16, 2026
- Market cap
- $1.36M
- P/E (TTM)
- –
- Dividend yield
- –
About Cannapharmarx
Pharmaceutical Preparations, SIC 2834
CannaPharmaRx, Inc. acquires, develops, and operates indoor cannabis cultivation facilities to produce medical cannabis and craft products. The company primarily produces and distributes dried cannabis flower, packaged and marketed as dried flower and trim shake across premium and medium quality batches. Its operations encompass standard cultivation, processing, and distribution of cannabis through its operating subsidiary. Target markets for its cannabis products include consumers and wholesale channels in Canada, Germany, Israel, and Portugal.
Operationally, the company leases and runs a 55,000-square-foot indoor cultivation facility in Cremona, Alberta, which features six operational growing rooms alongside a drying and packing room. Its corporate workforce consists of twenty-six full-time employees, supplemented by temporary casual staff during active production cycles. The company maintains its principal executive headquarters in Mountain View County, Alberta, Canada, with historical roots tracing back to its original corporate incorporation in Colorado.
Summary of the business section of Cannapharmarx's latest annual report, written by StockData.
Company profile
Company
- Legal name
- CANNAPHARMARX, INC.
- Founded
- 1998
- Headquarters
- Mountain View County, Alberta, Canada
- Address
- 4439 Township Rd 304 T0M 0R0
- Phone
- (949) 652-6838
- Website
- cannapharmarx.com
- Employees
- 26, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- BARZILY AND CO., CPAs, Jerusalem, Israel
Stock & identifiers
- Ticker
- CPMD
- Exchange
- OTC
- Shares outstanding
- 709M, Aug 18, 2026
- Public float
- $2.58M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-10 reverse, Nov 10, 2006
- SEC CIK
- 1081938
- EIN
- 27-4635140
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Elliot Zemel | Director | 23,368,212 |
Employees
Headcount reported in annual reports
“We currently employ twenty-six full-time employees and a fluctuating number of casual staff on an as-needed basis depending on the volume of work during production.”
Corporate history
Events identified from SEC filings